Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Novavax, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
NVAX
Nasdaq
2836
global.novavax.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Novavax, Inc.
Novavax (NVAX) Rises But Trails Market: What Investors Should Know
- Feb 4th, 2025 10:45 pm
Health, pharma stocks fall as RFK Jr. clears crucial vote
- Feb 4th, 2025 4:55 pm
Novavax, Inc. (NASDAQ:NVAX) About To Shift From Loss To Profit
- Feb 4th, 2025 2:01 pm
Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know
- Feb 4th, 2025 2:00 pm
Novavax (NVAX) Increases Despite Market Slip: Here's What You Need to Know
- Jan 27th, 2025 10:45 pm
Moderna Yo-Yos After European Officials Ink Supply Deal For Covid Shots
- Jan 24th, 2025 9:14 pm
Wall Street Analysts Predict an 81.61% Upside in Novavax (NVAX): Here's What You Should Know
- Jan 22nd, 2025 2:55 pm
Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It
- Jan 22nd, 2025 2:00 pm
Novavax, Inc. (NVAX) Stock: The Under-the-Radar Stock Poised for Massive Upside in 2025
- Jan 21st, 2025 3:04 am
Here's How Donald Trump Could Shake Up Health Care — And Biotech Stocks
- Jan 17th, 2025 6:55 pm
Moderna stock forfeits gains as first US bird flu death puts vaccine development in focus
- Jan 8th, 2025 9:03 pm
Novavax (NASDAQ:NVAX) surges 35% this week, taking five-year gains to 171%
- Jan 8th, 2025 1:47 pm
Vaccine Stocks Jump After CDC Reports First US Bird-Flu Death
- Jan 8th, 2025 11:52 am
Strength Seen in Novavax (NVAX): Can Its 10.9% Jump Turn into More Strength?
- Jan 8th, 2025 11:09 am
Moderna, BioNTech, Novavax Surge After CDC Reports Two-Week Covid Spike
- Jan 7th, 2025 9:12 pm
Vaccine Stocks Surge: Moderna Jumps 11% as COVID-19 and Flu Fears Reignite Immunization Demand
- Jan 7th, 2025 4:26 pm
Novavax Cut Its Outlook Despite Beating Third-Quarter Forecasts. Is It A Sell In December 2024?
- Dec 13th, 2024 2:59 pm
Novavax Advances Corporate Growth Strategy Through Sanofi Partnership, Including Achievement of First $50 Million Milestone
- Dec 13th, 2024 1:00 pm
Why Is Novavax (NVAX) Up 13.6% Since Last Earnings Report?
- Dec 12th, 2024 4:30 pm
Institutional investors control 53% of Novavax, Inc. (NASDAQ:NVAX) and were rewarded last week after stock increased 6.3%
- Dec 12th, 2024 1:09 pm
Scroll